{{Rsnum
|rsid=2578189
|Gene=ATP5A1
|Chromosome=18
|position=46100734
|Orientation=plus
|GMAF=0.3361
|Gene_s=ATP5A1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 89.4 | 8.8 | 1.8
| HCB | 79.6 | 19.7 | 0.7
| JPT | 69.6 | 29.5 | 0.9
| YRI | 20.6 | 44.4 | 34.9
| ASW | 0.0 | 0.0 | 0.0
| CHB | 79.6 | 19.7 | 0.7
| CHD | 82.6 | 15.6 | 1.8
| GIH | 99.0 | 1.0 | 0.0
| LWK | 56.0 | 25.7 | 18.3
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 88.2 | 8.8 | 2.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=24373140
|Title=The importance of a large sample cohort for studies on modifier genes influencing disease severity in FAP patients
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}